Calamos Advisors LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$18,895,528
+11.6%
10,115,0000.0%0.09%
+15.6%
Q3 2022$16,926,000
-36.5%
10,115,000
-52.1%
0.08%
-33.0%
Q2 2022$26,667,000
-3.9%
21,131,0000.0%0.12%
+10.6%
Q1 2022$27,741,000
-10.0%
21,131,0000.0%0.10%
-9.6%
Q4 2021$30,817,000
-12.0%
21,131,000
-10.6%
0.12%
-24.8%
Q3 2021$35,035,000
+4.9%
23,631,000
-6.0%
0.15%0.0%
Q2 2021$33,392,000
+1.9%
25,131,0000.0%0.15%
-14.5%
Q1 2021$32,780,000
-46.7%
25,131,0000.0%0.18%
-49.9%
Q4 2020$61,472,000
+18.3%
25,131,000
+0.3%
0.36%
+6.9%
Q3 2020$51,955,000
-10.2%
25,051,000
-0.3%
0.33%
-18.3%
Q2 2020$57,829,000
+42.5%
25,136,000
-5.0%
0.41%
+28.6%
Q1 2020$40,570,000
-27.2%
26,471,000
-7.0%
0.32%
+15.2%
Q4 2019$55,765,000
+48.1%
28,471,0000.0%0.28%
+34.6%
Q3 2019$37,660,000
-40.8%
28,471,0000.0%0.20%
-41.9%
Q2 2019$63,578,000
+23.4%
28,471,0000.0%0.35%
+9.6%
Q1 2019$51,528,00028,471,0000.32%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 82,499,000$120,618,0003.75%
WOLVERINE ASSET MANAGEMENT LLC 76,497,000$112,118,0001.04%
Verition Fund Management LLC 24,689,000$36,219,0000.26%
Baker Brothers Advisors 29,174,000$42,695,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 6,858,000$10,032,0000.17%
LORD, ABBETT & CO. LLC 48,435,000$71,054,0000.16%
Calamos Advisors LLC 21,131,000$30,817,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 3,218,000$4,726,0000.10%
Point72 Asset Management, L.P. 9,507,000$13,948,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 10,000,000$14,609,0000.05%
View complete list of SAREPTA THERAPEUTICS INC shareholders